1. Barth M, Capelle HH, Weidauer S, Weiss C, Münch E, Thomé C, et al. Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke 2007;38:330–6.
2. Barth M, Pena P, Seiz M, Thomé C, Muench E, Weidauer S, et al. Effect of intraventricular nicardipine prolonged release implants on clinical and radiological outcome in patients following aneurysmal SAH. 2010 (In review).
3. Barth M, Thomé C, Schmiedek P, Weiss C, Kasuya H, Vajkoczy P. Characterization of functional outcome and quality of life following subarachnoid hemorrhage in patients treated with and without nicardipine prolonged-release implants. J Neurosurg. 2009;110:955–60.
4. Kasuya H. Clinical trial of nicardipine prolonged-release implants for preventing cerebral vasospasm: Multi-center cooperative study in Tokyo. Abstract book of the 10th international conference on cerebral vasospasm, Chongqing, China, 2009. p. 11.
5. Kasuya H, Onda H, Sasahara A, Takeshita M, Hori T. Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery 2005;56:895–902.